Brief Article
Copyright
©2010 Baishideng. All rights reserved.
World J Gastroenterol. Jan 14, 2010; 16(2): 256-263
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.256
Table 1 Demographic and clinicopathologic features of young age in control group n (%)
Features Group A (n = 350) Group B (n = 1500) Group C (n = 1150) Whole (n = 3000) P -value Age (median, yr) 24 ± 1.3 34 ± 2.4 44 ± 3.7 35 ± 4.9 NS Sex < 0.05 Male 150 (42.9) 750 (50.0) 750 (65.2) 1650 (55.0) Female 200 (52.1) 750 (50.0) 400 (34.8) 1350 (45.0) Indication of endoscopy NS No symptom 117 (33.4) 514 (34.2) 499 (43.4) 1130 (37.7) Dyspepsia 211 (60.3) 798 (53.2) 687 (59.7) 1696 (56.5) Weight loss 13 (4.7) 26 (1.7) 28 (2.4) 67 (2.2) Nausea/poor oral intake 54 (15.4) 155 (10.3) 308 (26.8) 517 (17.2) Others 17 (4.9) 37 (2.5) 28 (2.4) 82 (2.7) H. pylori (+) & combined IM< 0.05 Male 5 (3.3) 65 (4.3) 74 (9.9) 144 (8.7) Female 11 (5.5) 89 (11.9) 56 (14.0) 156 (11.6)
Table 2 Demographic and clinicopathologic features of young age GC patients n (%)
Features Group A (n = 371) Group B (n = 1584) Group C (n = 1287) Whole (n = 3242) P -value Age (median, yr) 26 ± 3.2 36 ± 2.8 43 ± 1.4 38 ± 5.6 NS Sex < 0.05 Male 144 (38.8) 798 (50.4) 805 (62.5) 1747 (53.9) Female 227 (61.2) 786 (49.6) 482 (37.5) 1495 (46.1) Survival (median, mo)1 29.8 ± 4.2 31.7 ± 5.3 33.2 ± 3.8 32.4 ± 3.3 NS Tumor size (mean, cm) 5.6 ± 3.2 5.2 ± 3.8 4.9 ± 2.9 5.14 ± 4.4 NS Number < 0.05 Multiple 1 (0.2) 5 (0.3) 8 (0.6) 14 (0.4) Single 370 (99.8) 1579 (99.8) 1279 (99.4) 3228 (99.6) Site of disease < 0.05 Antrum 71 (19.1) 442 (27.9) 617 (48.0) 1130 (34.9) Body (lower and middle) 84 (22.6) 365 (23.0) 308 (23.9) 757 (23.3) Upper body and cardia 140 (37.8) 428 (27.1) 218 (16.9) 786 (24.2) Diffuse 76 (20.5) 349 (22.0) 144 (11.2) 569 (17.6) Pathology < 0.05 Adenocarcinoma Male 63 (43.8) 401 (50.3) 499 (62.0) 963 (55.1) Female 87 (38.3) 347 (44.1) 250 (51.9) 684 (45.8) Signet ring cell carcinoma Male 81 (56.2) 397 (49.7) 306 (38.0) 784 (44.9) Female 140 (61.7) 439 (55.9) 232 (48.1) 811 (54.2) Stage of disease < 0.05 Localized to stomach 34 (9.2) 190 (12.0) 181 (14.1) 405 (12.5) Regional metastasis2 71 (19.1) 491 (31.0) 475 (36.9) 1037 (32.0) Distant metastasis 266 (71.7) 903 (57.0) 631 (49.0) 1800 (55.5) Coincidence of IM < 0.05 Male 9 (6.3) 168 (21.1) 249 (31.0) 426 (24.4) Female 13 (5.7) 121 (15.4) 97 (20.1) 231 (15.5) H. pylori (+)25 (6.7) 378 (23.9) 472 (36.7) 875 (27.0) < 0.05
Table 3 Frequency of control group and young age GC, age-adjusted OR estimates and 95% CI by demographic and clinical characteristics, Korea, 1990 to 2008 n (%)
Risk factors GCs Controls Age-adjusted OR 95% CI P -valueMale Female Male Female Male Female Male Female Male Female High-risk diet1 Whole 694 (39.7) 440 (29.4) 341 (20.7) 265 (19.6) 2.53 1.71 2.17-2.95 1.34-2.03 < 0.001 < 0.001 Group A 54 (37.5) 40 (27.8) 31 (20.7) 25 (16.7) 2.30 1.50 1.37-3.87 0.87-2.57 0.002 0.034 Group B 311 (39.0) 239 (30.4) 153 (20.4) 151 (20.1) 2.49 1.73 1.99-3.13 1.37-1.29 < 0.001 < 0.001 Group C 329 (40.9) 161 (33.4) 157 (22.0) 89 (22.3) 2.61 1.75 2.08-3.27 1.307-2.37 < 0.001 < 0.001 Heavy smoking2 Whole 528 (30.2) 241 (16.1) 264 (16.0) 137 (10.1) 2.27 1.70 1.93-2.69 1.36-2.13 < 0.001 < 0.001 Group A 51 (35.4) 34 (15.0) 30 (20.0) 19 (9.5) 2.19 1.68 1.30-3.72 0.92-3.05 0.003 0.031 Group B 244 (30.6) 143 (18.2) 119 (15.9) 83 (11.1) 2.34 1.79 1.82-2.99 1.34-2.39 < 0.001 < 0.001 Group C 233 (28.9) 64 (13.2) 115 (15.3) 35 (8.75) 2.25 1.60 1.75-2.89 1.03-2.47 < 0.001 0.035 Heavy alcohol drinking3 Whole 608 (34.8) 168 (11.2) 301 (18.2) 91 (6.7) 2.39 1.52 2.04-2.81 1.34-2.29 < 0.001 < 0.001 Group A 54 (37.5) 26 (11.5) 28 (18.7) 12 (6.0) 2.61 2.02 1.54-4.45 0.99-4.13 < 0.001 0.052 Group B 293 (36.7) 81 (10.3) 142 (18.9) 47 (6.3) 2.48 1.72 1.97-3.14 1.18-2.50 < 0.001 0.005 Group C 261 (32.4) 61 (12.7) 131 (17.5) 32 (8.0) 2.14 1.73 1.68-2.72 1.60-2.54 < 0.001 0.019 Low socioeconomic condition4 Whole 414 (23.7) 323 (21.6) 279 (16.9) 206 (15.3) 1.53 1.53 1.29-1.81 1.26-1.86 < 0.001 < 0.001 Group A 28 (19.4) 44 (19.3) 21 (14) 27 (13.5) 1.42 1.54 0.76-2.64 0.99-3.03 0.003 0.009 Group B 191 (23.9) 168 (21.4) 135 (18.0) 122 (16.3) 1.43 1.40 1.12-1.84 1.082-1.81 0.004 0.011 Group C 195 (24.2) 111 (23.0) 123 (16.4) 57 (14.2) 1.63 1.80 1.27-2.10 1.27-2.56 < 0.001 0.001 Urban residence Whole 947 (54.2) 805 (53.8) 711 (43.1) 574 (42.5) 1.56 1.58 1.37-1.79 1.36-1.83 < 0.001 < 0.001 Group A 84 (58.3) 132 (58.1) 67 (44.7) 99 (49.5) 1.48 1.42 0.93-1.23 0.973-2.08 0.002 0.073 Group B 454 (56.9) 434 (55.2) 331 (44.1) 322 (42.9) 1.67 1.64 1.37-2.04 1.34-2.00 < 0.001 < 0.001 Group C 409 (50.8) 239 (49.6) 313 (38.9) 153 (38.2) 1.44 1.60 1.18-1.76 1.21-2.08 0.003 0.001 Occupational environment Whole 588 (33.6) 331 (22.1) 315 (19.1) 181 (13.4) 2.15 1.84 1.84-2.52 1.51-2.24 < 0.001 < 0.001 Group A 44 (30.6) 47 (20.7) 24 (16.0) 29 (14.5) 2.31 1.54 1.32-4.05 0.93-2.56 0.004 0.094 Group B 263 (33.0) 181 (23.0) 140 (18.7) 98 (13.1) 2.14 1.99 1.69-2.71 1.52-2.61 < 0.001 < 0.001 Group C 281 (34.9) 103 (21.4) 151 (20.1) 54 (13.5) 2.13 1.74 1.69-2.68 1.22-2.50 < 0.001 0.003 Family history of GC5 Whole 150 (8.6) 102 (6.8) 36 (2.2) 28 (2.1) 4.21 3.46 2.91-6.10 2.26-5.29 < 0.001 < 0.001 Group A 11 (7.6) 14 (6.2) 3 (2.0) 4 (2.0) 4.05 3.22 1.10-14.84 1.04-9.95 0.035 0.042 Group B 68 (8.5) 53 (6.7) 17 (2.3) 15 (2.4) 4.01 3.54 2.34-6.90 1.98-6.34 < 0.001 < 0.001 Group C 71 (8.8) 35 (7.2) 16 (2.1) 9 (2.3) 4.17 3.40 2.43-7.15 1.62-7.17 < 0.001 0.001 H. pylori (+) & combined IMWhole 367 (21.0) 231 (15.5) 144 (8.7) 156 (11.6) 2.78 1.40 2.26-3.42 1.13-1.74 < 0.001 < 0.001 Group A 11 (7.6) 13 (5.7) 5 (3.3) 11 (5.5) 2.40 1.04 0.71-7.08 0.46-2.39 0.051 0.192 Group B 155 (19.4) 121 (15.4) 65 (4.3) 89 (11.9) 2.54 1.35 1.87-3.46 1.00-1.81 < 0.001 0.045 Group C 201 (25.0) 97 (20.1) 74 (9.9) 56 (14.0) 3.04 1.55 2.28-4.06 1.08-2.22 < 0.001 0.017 BMI > 35 Whole 374 (21.4) 270 (18.1) 201 (12.4) 159 (11.8) 1.94 1.65 1.63-2.37 1.34-2.04 < 0.001 < 0.001 Group A 30 (20.8) 35 (15.4) 18 (12.0) 19 (9.5) 1.93 1.74 1.09-2.35 0.96-3.15 0.043 0.066 Group B 176 (22.1) 139 (17.7) 95 (12.7) 89 (11.9) 1.95 1.60 1.49-2.56 1.20-2.12 < 0.001 0.001 Group C 168 (20.9) 96 (19.9) 92 (12.3) 51 (12.8) 1.89 1.70 1.43-2.49 1.78-2.46 < 0.001 0.005
Table 4 Frequency of control group and young age GC, age-adjusted OR estimates and 95% CI by hormonal and reproductive characteristics, Korea, 1990 to 2008 n (%)
Risk factors GCs Controls OR 95% CI P -value Frequent use of oral contraceptives 432 (28.9) 201 (14.0) 2.50 2.06-3.00 < 0.001 Age at first pregnancy (≥ 5 mo)1 Age < 25 225 (15.1) 243 (17.0) 0.86 0.70-1.05 0.127 Age ≥ 25, < 35 848 (56.7) 977 (68.3) 1.05 0.73-1.50 0.438 Age ≥ 35 422 (28.2) 211 (14.7) 2.27 1.89-2.73 < 0.001 Parity (live births) Nullipara or few (1-2) 779 (52.1) 487 (34.0) 2.11 182-2.45 < 0.001 Many (≥ 3) 431 (28.8) 629 (44.0) 0.52 0.44-0.60 < 0.001 History of lactation 313 (20.9) 414 (28.9) 0.68 0.58-0.79 < 0.001 Poor nutritional status2 252 (16.9) 122 (8.5) 2.12 1.73-2.73 < 0.001 Age at menarche (yr) Age < 12 308 (20.6) 258 (18.0) 1.18 0.98-1.14 0.078 Age ≥ 12, < 16 956 (63.9) 930 (65.0) 0.95 0.62-1.44 0.102 Age ≥ 16 231 (15.5) 243 (17.0) 0.89 0.73-1.09 0.262 Premenopausal state (preoperative) 134 (9.0) 138 (9.6) 0.92 0.72-1.18 0.526 Other gynecologic malignancy3 19 (1.3) 16 (1.1) 1.14 0.58-2.22 0.237